Jennison Associates LLC Decreases Stock Position in Agilent Technologies, Inc. (NYSE:A)

Jennison Associates LLC cut its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 36.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 373,381 shares of the medical research company’s stock after selling 213,058 shares during the quarter. Jennison Associates LLC owned 0.13% of Agilent Technologies worth $50,160,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Livelsberger Financial Advisory bought a new position in shares of Agilent Technologies during the third quarter valued at about $28,000. CKW Financial Group raised its position in Agilent Technologies by 114.9% during the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 100 shares during the last quarter. Ashton Thomas Securities LLC purchased a new stake in Agilent Technologies in the 3rd quarter worth approximately $31,000. Fortitude Family Office LLC grew its position in shares of Agilent Technologies by 68.3% in the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after buying an additional 95 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new position in shares of Agilent Technologies during the third quarter valued at approximately $38,000.

Analyst Ratings Changes

A has been the subject of a number of research analyst reports. JPMorgan Chase & Co. dropped their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, November 26th. Wells Fargo & Company cut their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research note on Monday, December 9th. Sanford C. Bernstein decreased their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Finally, Citigroup increased their target price on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, Agilent Technologies currently has an average rating of “Hold” and a consensus target price of $143.62.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. This represents a 4.60 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Agilent Technologies Trading Down 1.1 %

Agilent Technologies stock opened at $147.06 on Wednesday. Agilent Technologies, Inc. has a 12 month low of $124.16 and a 12 month high of $155.35. The company has a market capitalization of $42.00 billion, a price-to-earnings ratio of 33.27, a price-to-earnings-growth ratio of 4.10 and a beta of 1.07. The business’s fifty day simple moving average is $140.80 and its two-hundred day simple moving average is $138.96. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. The company had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. Agilent Technologies’s revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.38 EPS. As a group, equities analysts predict that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st were given a $0.248 dividend. The ex-dividend date was Tuesday, December 31st. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a yield of 0.67%. Agilent Technologies’s dividend payout ratio is 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.